Aug 5, 2022
Vanity Capital Inc. and Akseera Pharma Corp. Announce Reverse Takeover Transaction and Concurrent Financing
Vanity Capital Inc. and Akseera Pharma Corp. Announce Reverse Takeover Transaction and Concurrent Financing
Vanity Capital Inc. (TSX VENTURE: VYC) (the “Company“) is pleased to announce that it has entered into a binding letter of intent dated Nov. 27, 2018, (the “Letter of Intent“) with Akseera Pharma Corp., a private Canadian corporation (“Akseera“), in connection with a proposed reverse take-over of the Company (the “Proposed Transaction“) subject to approval of the TSX Venture Exchange (the…
View On WordPress